📰 Scientific Selection Board News
Scientific Selection Board News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Scientific Selection Board. Real-time updates on events, politics, business and more.
December 15, 2022
/PRNewswire/ -- Novo Holdings REPAIR Impact Fund today announces that it has participated in the EUR 72 million financing of MinervaX, a privately held Danish...
December 15, 2020
Share: COPENHAGEN, Denmark, Dec. 15, 2020 /PRNewswire/ -- MinervaX, a privately held Danish biotechnology company developing a novel vaccine against Group B Streptococcus (GBS), announced today that it has raised an upsized EUR 47.4 million Series B financing. The round included new investors Sanofi Ventures, Wellington Partners, Adjuvant Capital, and Industrifonden, along with existing investors Novo Holdings REPAIR Impact Fund, Sunstone Life Science Ventures, and LF Investment. Proceeds wil...
December 15, 2020
(1) - On the back of highly promising Phase Ib data, MinervaX has raised financing from leading investors to accelerate development of its novel vaccine through the end of Phase II trials and preparations for Phase III pivotal trials - Novel vaccine candidate offers viable alternative to antibiotics, thereby strategically aligned with REPAIR Impact Funds mission to combat antimicrobial resistance (AMR) - - Group B Streptococcus (GBS) is one of the leading causes of stillbirth and infant mor...